Xenon Pharmaceuticals Stock Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for Xenon Pharmaceuticals stock have an average target of 57, with a low estimate of 49 and a high estimate of 67. The average target predicts an increase of 72.57% from the current stock price of 33.03.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$49	$57	$55	$67
Change	+48.35%	+72.57%	+66.52%	+102.85%

* Price targets were last updated on Feb 24, 2025.

Analyst Ratings

The average analyst rating for Xenon Pharmaceuticals stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	5	5	5	3	3	3
Buy	5	4	4	4	4	4
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	9	9	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $53	Strong Buy	Reiterates	$53	+60.46%	Feb 24, 2025
David Hoang Deutsche Bank	Deutsche Bank	Strong Buy Initiates $67	Strong Buy	Initiates	$67	+102.85%	Feb 11, 2025
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $53	Strong Buy	Reiterates	$53	+60.46%	Dec 12, 2024
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $53	Strong Buy	Reiterates	$53	+60.46%	Nov 13, 2024
Serge Belanger Needham	Needham	Strong Buy Reiterates $60	Strong Buy	Reiterates	$60	+81.65%	Nov 13, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

1.90M

Revenue Next Year

31.48M

from 1.90M

1,553.36%

from 1.90M

EPS This Year

-4.15

from -3.01

EPS Next Year

-4.60

from -4.15

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	32.17M	18.44M	9.43M	-	-	1.90M	31.48M	147.35M
Revenue Growth	371.02%	-42.68%	-48.83%	-	-	-	1,553.36%	368.07%
EPS	-0.80	-1.77	-2.06	-2.73	-3.01	-4.15	-4.60	-4.01
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	19	18	16

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	8.4M	169.3M	318.5M
Avg	1.9M	31.5M	147.4M
Low	n/a	n/a	40.8M

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	8,789.2%	911.8%
Avg	-	1,553.4%	368.1%
Low	-	-	29.6%

EPS Forecast

EPS	2025	2026	2027
High	-3.36	-3.85	-1.22
Avg	-4.15	-4.60	-4.01
Low	-4.58	-5.30	-5.64

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.